PMID- 9538962 OWN - NLM STAT- MEDLINE DCOM- 19980521 LR - 20221207 IS - 0149-5992 (Print) IS - 0149-5992 (Linking) VI - 21 IP - 1 DP - 1998 Jan TI - The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. PG - 2-8 AB - OBJECTIVE: To determine whether an intermittent very-low-calorie diet (VLCD) improves weight loss and glycemic control more than moderate caloric restriction alone. RESEARCH DESIGN AND METHODS: Individuals with type 2 diabetes (n = 54) who were > or = 20% over ideal body weight participated in a 20-week behavioral weight control program. Subjects were randomized to either a standard behavioral therapy (SBT) group or to one of two VLCD groups. SBT subjects received a 1,500-1,800 kcal/day diet throughout. Both VLCD groups followed a VLCD for 5 consecutive days during week 2, followed by either intermittent VLCD therapy for 1 day/week for 15 weeks (1-day) or for 5 consecutive days every 5 weeks (5-day), with a 1,500-1,800 kcal/day diet at other times. RESULTS: Both VLCD groups lost more weight than the SBT group over the 20 weeks (P = 0.04). Although the groups did not differ in fasting plasma glucose (FPG) changes at 20 weeks, more subjects in the 5-day group attained a normal HbA1c when compared with the SBT group (P = 0.04). This benefit was independent of the effects of weight loss. The best predictor of overall change in FPG and HbA1c was the FPG response during the first 3 weeks of the program. CONCLUSIONS: Periodic VLCDs improved weight loss in diabetic subjects. A regimen with intermittent 5-day VLCD therapy seemed particularly promising, because more subjects in this group attained a normal HbA1c. Moreover, the glucose response to a 3-week period of diet therapy predicted glycemic response at 20 weeks, and it was a better predictor of the 20-week response than initial or overall weight loss. FAU - Williams, K V AU - Williams KV AD - Department of Medicine, University of Pittsburgh School of Medicine, Pennsylvania, USA. kvw+@.pitt.edu FAU - Mullen, M L AU - Mullen ML FAU - Kelley, D E AU - Kelley DE FAU - Wing, R R AU - Wing RR LA - eng GR - 2T32-DK-07052-22/DK/NIDDK NIH HHS/United States GR - DK-29757/DK/NIDDK NIH HHS/United States PT - Clinical Trial PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Diabetes Care JT - Diabetes care JID - 7805975 RN - 0 (Blood Glucose) RN - 0 (Cholesterol, HDL) RN - 0 (Cholesterol, LDL) RN - 0 (Glycated Hemoglobin A) RN - 0 (Triglycerides) RN - 97C5T2UQ7J (Cholesterol) SB - IM MH - Adult MH - Aged MH - *Behavior Therapy MH - Blood Glucose/*metabolism MH - Body Mass Index MH - Cholesterol/blood MH - Cholesterol, HDL/blood MH - Cholesterol, LDL/blood MH - Diabetes Mellitus/diet therapy/physiopathology/*therapy MH - Diabetes Mellitus, Type 2/diet therapy/physiopathology/*therapy MH - *Diet, Reducing MH - Energy Intake MH - Female MH - Glycated Hemoglobin/analysis MH - Humans MH - Male MH - Middle Aged MH - *Obesity MH - Regression Analysis MH - Time Factors MH - Triglycerides/blood MH - *Weight Loss EDAT- 1998/04/16 00:00 MHDA- 1998/04/16 00:01 CRDT- 1998/04/16 00:00 PHST- 1998/04/16 00:00 [pubmed] PHST- 1998/04/16 00:01 [medline] PHST- 1998/04/16 00:00 [entrez] AID - 10.2337/diacare.21.1.2 [doi] PST - ppublish SO - Diabetes Care. 1998 Jan;21(1):2-8. doi: 10.2337/diacare.21.1.2.